Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Post by Hedgefundharryon Nov 18, 2019 3:22pm
167 Views
Post# 30366301

Here’s the lawsuit

Here’s the lawsuit

I told you was coming in previous posts!

ACB LOSS ALERT: ROSEN, A TOP RANKED LAW FIRM, Announces Investigation of Securities Claims Against Aurora Cannabis Inc. – ACB

NEW YORK--(BUSINESS WIRE)--

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Aurora Cannabis Inc. (ACB) resulting from allegations that Aurora may have issued materially misleading business information to the investing public.

On November 14, 2019, Aurora announced its First Quarter Results and Corporate Action Plan. The results included a 24% quarterly sequential drop in revenue including a 33% drop in consumer cannabis revenue. The results also included a greater EBITDA loss than the previous quarter at CA$39.7M EBITDA.

Aurora also announced a CA$190M reduction is capital expenditures, the halting of construction of the Aurora Nordic 2 facility in Demark, and its deferring final construction of its Aurora Sun facility. Finally, the Company announced that it would open an early conversion window for holders of CA$230M of convertible debentures.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Aurora investors. If you purchased shares of Aurora please visit the firm’s website at https://www.rosenlegal.com/cases-register-1724.html to join the class action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or cases@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20191118005710/en/
 

glta 

harry

 


Bullboard Posts